FindTrial
Sign In

TO CORRELATE THE BLOOD LEVELS OF IGE AND VITAMIN D3 WITH THE SEVERITY OF AN ALLERGIC CONDITION OF THE SKIN KNOWN AS ATOPIC DERMATITIS

CORRELATION BETWEEN SERUM IgE AND SERUM VITAMIN D3 LEVELS WITH THE SEVERITY OF ATOPIC DERMATITIS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/11/038280
Enrollment
62
Registered
2021-11-26
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Control Intervention1: cross sectional observational study: NIL

Sponsors

Father Muller Medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed cases of atopic dermatitis according to Hanifin Rajkaââ?¬•s Criteria. 2. Patients willing to take part in the study.

Exclusion criteria

Exclusion criteria: 1. Patients on antihistaminics, Vitamin D3 supplements, systemic corticosteroids, immunosuppressants. 2. Patients with non atopic eczemas. 3. Pregnant and lactating women. 4. Patients with Hyper IgE Syndrome 5. Patients with liver and gallbladder dysfunction. 6. Patients unwilling to take part in the study.

Design outcomes

Primary

MeasureTime frame
To see if atopic dermatitis has positive correlation with serum IgE and negative correlation with serum Vitamin D3 levelsTimepoint: By June 2022—

Secondary

MeasureTime frame
To establish if Vitamin D3 supplements can decrease the SCORAD INDEX and hence decrease the severity of Atopic dermatitis and its complicationsTimepoint: 18 months—

Countries

India

Contacts

Public ContactSuvidha Kamath

Father Muller Medical College

dr_martisj@yahoo.co.in9845148112

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026